O presente trabalho estuda algumas características epidemiológicas de 241 casos de Meningite tuberculosa de pessoas residentes na Grande São Paulo, nos anos de 1982 e 1983. O levantamento de casos foi realizado no Centro de Investigações de Saúde e outras fontes oficiais de informação e complementado pela visitação domiciliária que representou um recurso inestimável para o esclarecimento dos dados. Os casos foram analisados por região de residência, aspectos individuais, núcleos familiares, história da doença, hospitalização, seqüência de tratamento e conhecimento sobre a doença. Os resultados identificam condições insatisfatórias de vida na maioria da população, demora no diagnóstico por falhas assistenciais, alta letalidade hospitalar e desconhecimento do modo de transmissão e prevenção da tuberculose pela maioria das pessoas entrevistadas. O grupo de menores de 5 anos de idade foi o mais comprometido pela ocorrência de seqüelas e, a maior letalidade oi na faixa de 7-12 meses. Ao final do estudo, houve 45,7 por cento de cura, 27,8 por cento de óbito, 13,3 por cento de abandono. Em 13,2 por cento dos casos, alguns permaneciam em observação e outros desconhecidos pelo sistema de controle de notificações. / The present paper studies some epidemiological characteristics of 241 cases of tuberculous miningitis in persons living in the Great São Paulo, State of São Paulo, Brazil, in 1982 and 1983. The survey of cases was worked out at the Center of Health Investigation; other official sources have been consulted, too, being work complemented by domiciliary visitings which represented an invaluable resource for data enlightenment. The cases were analysed taking into account region of dwelling, individual aspects, familiar nucleus, disease history, hospitalization, treatment follow-up and knowledge about the disease. Results identify unsatisfactory life conditions for the majority of the population under study; delay in diagnosing the disease due to failures in assistance; high rate of hospital lethality and lack of knowledge on how tuberculosis is transmitted and prevented by the majority of the persons interviewed with. The age group of children below five years was the one most implicated in as to the occurence of the highest rate of lethality was presented by children aged 7-12 months. At the end of the study, there were 45.7 per cent of healings; 27.8 per cent of deaths; 13.3 per cent of treatment abandonment. In 13.2 per cent of the cases, some persons continued under observation and others remained unknown by the Health System of notifications.

O presente trabalho estuda algumas características epidemiológicas de 241 casos de Meningite tuberculosa de pessoas residentes na Grande São Paulo, nos anos de 1982 e 1983. O levantamento de casos foi realizado no Centro de Investigações de Saúde e outras fontes oficiais de informação e complementado pela visitação domiciliária que representou um recurso inestimável para o esclarecimento dos dados. Os casos foram analisados por região de residência, aspectos individuais, núcleos familiares, história da doença, hospitalização, seqüência de tratamento e conhecimento sobre a doença. Os resultados identificam condições insatisfatórias de vida na maioria da população, demora no diagnóstico por falhas assistenciais, alta letalidade hospitalar e desconhecimento do modo de transmissão e prevenção da tuberculose pela maioria das pessoas entrevistadas. O grupo de menores de 5 anos de idade foi o mais comprometido pela ocorrência de seqüelas e, a maior letalidade oi na faixa de 7-12 meses. Ao final do estudo, houve 45,7 por cento de cura, 27,8 por cento de óbito, 13,3 por cento de abandono. Em 13,2 por cento dos casos, alguns permaneciam em observação e outros desconhecidos pelo sistema de controle de notificações. / The present paper studies some epidemiological characteristics of 241 cases of tuberculous miningitis in persons living in the Great São Paulo, State of São Paulo, Brazil, in 1982 and 1983. The survey of cases was worked out at the Center of Health Investigation; other official sources have been consulted, too, being work complemented by domiciliary visitings which represented an invaluable resource for data enlightenment. The cases were analysed taking into account region of dwelling, individual aspects, familiar nucleus, disease history, hospitalization, treatment follow-up and knowledge about the disease. Results identify unsatisfactory life conditions for the majority of the population under study; delay in diagnosing the disease due to failures in assistance; high rate of hospital lethality and lack of knowledge on how tuberculosis is transmitted and prevented by the majority of the persons interviewed with. The age group of children below five years was the one most implicated in as to the occurence of the highest rate of lethality was presented by children aged 7-12 months. At the end of the study, there were 45.7 per cent of healings; 27.8 per cent of deaths; 13.3 per cent of treatment abandonment. In 13.2 per cent of the cases, some persons continued under observation and others remained unknown by the Health System of notifications.

Master of Public Health - MPH / Meningitis is a common opportunistic infection and an important cause of mortality among people living with HIV and AIDS globally. This study investigated meningitis in adults living with HIV and AIDS admitted to the medical wards of Livingstone tertiary hospital in Port Elizabeth in 2018 and determined the prevalence of its aetiological types, clinical presentations, diagnostic challenges, treatment outcomes and predictors of prognosis.

La tuberculose (TB) est encore aujourd’hui une cause majeure de morbidité et mortalité dans le monde. Sa maitrise a été rendue difficile par l’épidémie de VIH et la résistance au antituberculeux. La méningite tuberculose (MTB), est la forme la plus grave de TB et est un des indicateurs utilisés pour la politique vaccinale par le BCG. La multirésistance aux antituberculeux (MDR) qui pose des problèmes diagnostiques et thérapeutiques est surveillée depuis 1992 en France. En revanche, la mono-résistance à la Rifampicine (mono-RMP-R) qui représente une première étape vers la TB MDR est rarement étudiée et le devenir des malades est inconnu en France. Notre travail a été axé sur l’épidémiologie de la MTB et l’impact des modifications de stratégie vaccinale par le BCG. Nous avons pour cela utilisé deux systèmes de surveillance de la tuberculose en France : un réseau national de laboratoires coordonné par le centre national de référence des mycobactéries (CNR), et le système de la déclaration obligatoire (DO), coordonné par l’Institut de Veille Sanitaire (InVS). Nous avons également utilisé le réseau du CNR pour évaluer la monorésistance à la rifampicine dans la TB en France. Nous avons tout d’abord évalué le taux d’incidence de la tuberculose du système nerveux central à culture positive (TB SNC C+) en France en 2007 (année de modification de la politique vaccinale) et son évolution entre 1990 et 2007. En 2007, la TB SNC C+ représentait moins de 1% de tous les cas tuberculose à culture positive et son incidence était de 0,5/million d’habitants. La sensibilité du réseau du CNR était de 79,4%. Pour évaluer l’évolution de la TB SNC C+ entre 1990 et 2007, nous avons utilisé une sensibilité « moyenne » dérivée de la sensibilité du CNR pour l'année 2000 (75,6%) et celle pour l'année 2007 pour corriger le nombre de cas signalés dans chacune des 4 études (1990, 1995, 2000, 2007). Nous avons observé une diminution de 62% du nombre corrigé de TB SNC C+ en 17 ans (90 à 35 cas) et du taux d'incidence corrigé (de 1,6 à 0,55 cas par million d'habitants) (P < 0.001). Ensuite, nous avons mesuré l’impact des deux changements majeurs de la politique vaccinale par le BCG en 2006 (arrêt de la multipuncture) et 2007 (arrêt du BCG obligatoire), sur l’épidémiologie de la MTB chez les enfants <6 ans en France entre 2000 et 2011. Au total, 10 cas de MTB à culture positive et 17 cas de MTB possibles (culture négative ou inconnue) ont été identifiés, avec un taux d’incidence annuel variant de 0,16 à 0,66 cas/10 million habitants. En Ile de France où tous les enfants sont considérés « à risque » et donc devraient tous être vaccinés, ou dans les autres régions, où seuls les enfants à risque sont vaccinés depuis 2007, il n’existait aucune différence significative des taux d'incidence annuels pour chaque cohorte d’un an. Ces résultats renforcent la décision d'arrêter de la vaccination universelle par le BCG en 2007. Toutefois une surveillance étroite de la TB SNC dans les années à venir sera nécessaire pour évaluer l'impact long-terme de la nouvelle stratégie vaccinale. Finalement, nous avons mis en place par le biais du réseau des laboratoires du CNR une cohorte rétrospective des cas de TB mono-RMP-R diagnostiqués en France entre 2005 et 2010. Au total, 39 cas de TB mono-RMP-R (soit 0.12% des cas de TB) ont été recensés. Parmi tous ces patients, 19 cas (49%) avaient un antécédent de traitement de leur tuberculose, et 9 (23%) étaient infectés par le VIH. Les données sur le traitement et le devenir étaient disponibles pour 30 des 39 patients et seulement 20 (67%) ont été considérés guéris. Les traitements reçus tant en terme de drogues que de durée étaient hétérogènes. Ces résultats suggèrent qu’il faut améliorer la prise en charge des malades atteints de TB mono-RMP-R en France. / Tuberculosis (TB) remains a major cause of morbidity and mortality worldwide, partly because of drug resistance anf the HIV epidemics. Tuberculous meningitis (TBM) is the most severe form of the tuberculosis disease, and is one of the indicators used for the BCG vaccination policy. Multidrug resistant tuberculosis (MDR-TB), which poses diagnostic and therapeutic problems, has been monitored since 1992 in France. On the opposite, rifampicin mono-resistance (RMR) tuberculosis (TB) which represents a first step toward MDR-TB is rarely studied and the impact of rifampicin mono-resistance on patient’s outcome is unknown in France. Our work was focused on the epidemiology of MTB and the impact of changes in the BCG vaccination strategy. We used two systems implemented for the surveillance of TB in France: a nationwide laboratory network coordinated by the National Reference Centre (NRC) for Mycobacteria and Resistance of Mycobacteria to Anti-tuberculosis Drugs and the mandatory notification system of TB (MNS) coordinated by the National Institute for Public Health Surveillance (Institut de Veille Sanitaire, InVS). The NRC network was also used to evaluate Rifampicin mono-resistant tuberculosis in France. First, we assessed the incidence rate of culture-positive (C+) central nervous system tuberculosis (CNS TB) in France in 2007 (the year of the changing policy on BCG vaccination) and its time trend between 1990 and 2007. In 2007, CNS TB represented less than 1% of all culture-positive TB cases and its incidence was around 0.50 per million inhabitants. The 2007 sensitivity of the NRC was 79.4%. To assess the evolution of C+ CNS TB between 1990 and 2007, we used an average sensitivity derived from the 2000 sensitivity of the NRC (75.6%) and the sensitivity for the year 2007. The average sensitivity was used to correct the number of C+ CNS TB reported in four surveys (1990, 1995, 2000, 2007). There was a major decrease of 62% in the extrapolated number of C+ CNS TB in seventeen years (from 90 to 35 cases), and in the extrapolated incidence rate (from 1.6 to 0.55 cases per million inhabitants) (P < 0.001). Then, we measured the impact of two major changes in BCG vaccination policy in 2006 (disappearance of the multipuncture device for BCG) and 2007 (end of compulsory BCG vaccination) on the epidemiology of TBM in children under 6 years in France between 2000 and 2011. Overall, 10 culture-positive and 17 possible (negative-culture or unknown microbiological result) cases of TBM were identified, with an annual incidence rate varying from 0.16 to 0.66 cases / 10 million inhabitants. In Ile-de-France, where all children are considered “at risk” and therefore should all be vaccinated, and in the other regions where only at-risk children are considered for vaccination since 2007, no statistically significant differences in the annual incidences rates for each one-year age-group cohort could be observed. These results reinforce the 2007 decision to stop universal BCG vaccination. However, a close monitoring of CNS TB in the coming years will be needed to assess the long-term impact of the new vaccination policy. Finally, we built, through the NRC national network of laboratories, a retrospective cohort of RMR TB cases diagnosed between 2005 and 2010. A total of 39 cases with RMR TB were identified (0.12% of all TB culture positive cases). Among all patients, 19 (49%) had a previous history of TB treatment, and 9 (23%) were HIV-coinfected. Data about treatment and outcome were available for 30 of 39 patients and only 20 (67%) were considered as cured. Treatments received both in terms of drugs and duration were heterogeneous. These results suggest the need to improve the management of patients with RMR TB in France.